Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pulmonary disease in the immunocompromised host. 1.

E C Rosenow, W R Wilson, F R Cockerill

    Mayo Clinic Proceedings
    |July 1, 1985
    PubMed
    Summary

    Pulmonary complications in immunocompromised patients are often fatal without intervention. Understanding compromised host defenses, like reduced granulocytes or lymphocytes, helps narrow the diagnosis for effective treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Elective Localization and Focal Infection from Oral Sepsis.

    The Dental register·2021
    Same author

    Inhibition controls for qualitative real-time PCR assays: are they necessary for all specimen matrices?

    Journal of clinical microbiology·2014
    Same author

    Multiplex Polymerase Chain Reaction Detection of vanA, vanB, vanC-1, and vanC-2/3 Genes in Enterococci.

    Methods in molecular medicine·2011
    Same author

    Studies on the nature of antibodies produced in vitro from bacteria with hydrogen peroxide and heat.

    Journal of bacteriology·2010
    Same author

    Studies on the relation of pneumotropic streptococci influenza virus.

    American journal of clinical pathology·2010
    Same author

    Specific types of alpha streptococcal antigen in unpotable water and water supplies.

    American journal of clinical pathology·2010

    Area of Science:

    • Pulmonology
    • Immunology
    • Oncology

    Background:

    • Pulmonary complications are a leading cause of mortality in immunocompromised patients.
    • Prompt clinical intervention is crucial for managing diffuse pulmonary disease in this population.
    • Differential diagnosis includes infection, disease recurrence, drug reactions, and unrelated conditions.

    Purpose of the Study:

    • To outline the differential diagnosis of diffuse pulmonary disease in immunocompromised hosts.
    • To emphasize the importance of understanding host defense mechanisms in guiding diagnosis and treatment.
    • To highlight the frequency of multiple concurrent pulmonary complications.

    Main Methods:

    • Review of clinical presentations and diagnostic challenges in immunocompromised patients with pulmonary disease.
    • Analysis of common host defense impairments (granulocyte, B-lymphocyte, T-lymphocyte deficiencies).
    • Categorization of pulmonary complications, including infectious and non-infectious causes.

    Main Results:

    • Diffuse pulmonary disease in immunocompromised hosts has a broad differential diagnosis.
    • Impaired host defenses (granulocytopenia, lymphocytopenia) correlate with specific opportunistic infections.
    • Up to one-third of patients experience multiple pulmonary complications.
    • Non-infectious pulmonary complications, including drug-induced disease and pulmonary emboli, occur in up to 25% of cases.

    Conclusions:

    • Understanding the specific type of host defense impairment aids in narrowing the differential diagnosis.
    • Empiric therapy can be guided by knowledge of which organisms are associated with specific immune deficiencies.
    • Recognizing non-infectious causes is critical, as they often mimic infections and are frequently associated with fever.

    Related Experiment Videos